True North Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-5,800
| Closed | -$503K | – | 199 |
|
|
2023
Q2 | $503K | Sell |
5,800
-2,900
| -33% | -$251K | 0.14% | 123 |
|
|
2023
Q1 | $846K | Hold |
8,700
| – | – | 0.25% | 88 |
|
|
2022
Q4 | $900K | Hold |
8,700
| – | – | 0.31% | 79 |
|
|
2022
Q3 | $737K | Hold |
8,700
| – | – | 0.24% | 86 |
|
|
2022
Q2 | $720K | Hold |
8,700
| – | – | 0.22% | 96 |
|
|
2022
Q1 | $670K | Hold |
8,700
| – | – | 0.18% | 107 |
|
|
2021
Q4 | $768K | Hold |
8,700
| – | – | 0.13% | 125 |
|
|
2021
Q3 | $672K | Hold |
8,700
| – | – | 0.13% | 131 |
|
|
2021
Q2 | $725K | Buy |
8,700
+3,200
| +58% | +$267K | 0.15% | 118 |
|
|
2021
Q1 | $415K | Hold |
5,500
| – | – | 0.1% | 146 |
|
|
2020
Q4 | $482K | Buy |
5,500
+2,619
| +91% | +$230K | 0.12% | 125 |
|
|
2020
Q3 | $219K | Buy |
+2,881
| New | +$219K | 0.06% | 165 |
|